What is the appropriate levetiracetam (Lerace) dosage based on body weight?

Levetiracetam (Lerace) Weight-Based Dosing

For acute seizure management in pediatric patients, use levetiracetam 40 mg/kg IV (maximum 2,500 mg) as a loading dose, followed by maintenance dosing of 15-30 mg/kg IV every 12 hours (maximum 1,500 mg per dose) depending on clinical context. 1

Loading Dose for Acute Seizures

Status Epilepticus (Convulsive or Non-Convulsive):

• Loading dose: 40 mg/kg IV (maximum 2,500 mg) as a bolus 1
• This dose is given in addition to any maintenance dose the patient may already be receiving
• Can be administered rapidly as undiluted IV push over 5 minutes, which is safe and well-tolerated even at high doses 2

Maintenance After Status Epilepticus Resolution:

• Non-convulsive status epilepticus: 15 mg/kg IV every 12 hours (maximum 1,500 mg) 1
• Convulsive status epilepticus: 30 mg/kg IV every 12 hours OR increase prophylaxis dose by 10 mg/kg (to 20 mg/kg) every 12 hours (maximum 1,500 mg) 1

Chronic Epilepsy Management (Oral Dosing)

Children (4-16 years):

• Starting dose: 10 mg/kg twice daily 3
• Target therapeutic dose: 20 mg/kg twice daily to achieve the 6-20 mg/L trough concentration range 3
• Maximum daily dose: 60 mg/kg/day 4

Infants and Young Children (1 month to <4 years):

• 20 mg/kg/day divided into two doses 5, 4
• These younger patients have 30-40% higher apparent clearance than adults, requiring higher weight-normalized doses 5, 4
• Half-life is shorter (5.3 hours in infants vs. 6-7 hours in older children) 5

Children with Obesity:

• For children weighing <75 kg: use standard weight-based dosing
• For children weighing ≥75 kg: consider weight-tiered dosing to avoid excessive exposure 6
• Children with obesity have lower weight-normalized clearance (3.71 vs. 4.77 L/h/70 kg in normal weight children) 6

Adult Dosing for Reference

Emergency Department Loading (when resuming therapy):

• 1,500 mg oral or IV load 7
• Rapid IV loading up to 60 mg/kg is safe and well-tolerated 7

High-Dose Loading in Status Epilepticus:

• Doses ≥30 mg/kg (up to 4,500 mg) are more effective than <30 mg/kg for benzodiazepine-refractory status epilepticus 8
• 99.4% of high doses (2,500-4,500 mg) administered as undiluted IV push were well-tolerated 9

Key Clinical Considerations

Renal Adjustment:

• Levetiracetam is renally cleared; dose reduction required in renal insufficiency 10
• Creatinine clearance significantly influences drug clearance 10

Drug Interactions:

• Enzyme-inducing AEDs (carbamazepine, phenytoin): increase levetiracetam clearance by 9-22% 10
• Valproate: decreases clearance by 18.8% 10
• However, no clinically significant pharmacokinetic interactions requiring routine dose adjustment 3

Age-Related Pharmacokinetics:

• Apparent clearance is highest in infants and young children (1.43-1.46 mL/min/kg) 5, 4
• Clearance decreases with age: children have 30-40% higher clearance than adults 4
• This necessitates higher weight-based doses in younger patients 10, 5

Administration Pearls

IV Administration:

• Undiluted IV push over 5 minutes is safe, even for doses up to 4,500 mg 9, 2
• Reduces time to administration by approximately 18 minutes compared to diluted infusion in status epilepticus 2
• Significantly reduces drug waste (18.7% vs. 57.6% with diluted bags) 2
• No increased incidence of hemodynamic disturbances or infusion reactions with undiluted administration 2

Common Pitfalls:

• Don't underdose young children—they require higher mg/kg doses than adults due to faster clearance
• Don't forget to adjust for renal function
• In obesity, avoid simple total body weight dosing above 75 kg to prevent excessive exposure
• For status epilepticus, the 40 mg/kg loading dose is given in addition to maintenance dosing, not as a replacement